Skip to main content
. 2019 Dec 27;11(2):415–425. doi: 10.1111/1759-7714.13285

Figure 2.

Figure 2

MiR‐148b inhibited NSCLC migration and invasion. (a) Measurement of miR‐148b level after treated with miR‐148b mimic or inhibitor in NSCLC cells. (b) A549 and H1299 cells viability measured after treated with miR‐2861 mimic or miR‐2861 inhibitor by MTT (Inline graphic) miR‐148b inhibitor, (Inline graphic) control inhibitor, (Inline graphic) miR‐148b mimic, and (Inline graphic) control mimic. (c) Representative images and quantitation of cell migration and (d) cell invasion after re‐expression or knockdown of miR‐148b in NSCLC cells. (c, d) (Inline graphic) control mimic, (Inline graphic) miR‐148b mimic, (Inline graphic) control inhibitor and (Inline graphic) miR‐148b inhibitor.